[LGND] YoY Quarter Result on 30-Sep-2009 [#Q3]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
09-Nov-2009
Financial Year
2009
Quarter
30-Sep-2009 [#Q3]
Profit Trend
QoQ- 208.09%
YoY- 109.95%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
Revenue 6,375 5,741 7,802 7,901 5,248 5,479 36,707 -25.28%
PBT -52 -3,884 -11,436 1,055 -6,134 -7,222 -16,969 -61.85%
Tax 142 22 419 -748 2,990 -2,360 -828 -
NP -194 -3,906 -11,843 1,803 -18,125 1,248 -14,918 -51.47%
Tax Rate - - - 70.90% - - - -
Total Cost 6,569 9,647 19,645 6,098 23,373 4,231 51,625 -29.05%
Ratio Analysis
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
NP Margin -3.04 -68.04 -151.79 22.82 -345.37 22.78 -40.64 -35.06%
Per Share
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
EPS -0.01 -0.20 -0.60 0.12 -1.14 0.06 -1.14 -54.55%
EPS Diluted -0.01 -0.20 -0.60 0.12 -1.14 0.06 -1.14 -54.55%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.